Structural and kinetic basis for selective inhibition of canine myeloperoxidase by staphylococcal peroxidase inhibitor (SPIN) orthologs
Journal of Biological Chemistry · 2026-12 · 302 (12) · 113649
DOI: 10.1016/j.jbc.2026.113649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-12. Verfasst von Soheila Fatehi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biophysics, Kansas State University, Manhattan, Kansas, USA. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Staphylococcus aureus and related species are highly adapted to their hosts and have evolved numerous strategies to evade the innate immune system. The Staphylococcal Peroxidase Inhibitor (SPIN) is a small, secreted protein that inhibits myeloperoxidase (MPO). SPIN blocks the MPO active site and prevents production of cytotoxic hypohalous acids within the neutrophil phagosome, thereby enabling evasion of oxidative killing. Staphylococcus aureus is primarily a human pathogen, and its SPIN protein cannot inhibit MPO from most non-human species. This raises questions as to whether staphylococci adapted to alternative mammalian hosts might produce SPIN proteins with similarly strict preferences for MPO from those species. We tested this hypothesis by isolating canine MPO (cMPO) from abscess samples obtained for veterinary diagnostic purposes and exploring its inhibition profile by a panel of SPIN orthologs. Across two independent trials, SPIN proteins from known canine pathogens bound to and inhibited cMPO much more potently than human MPO. We also found that this increased affinity and potency arises from corresponding increases in the association rate constant (ka) for cMPO as compared to human MPO. A 2.10 Å resolution co-crystal structure of cMPO inhibited by SPIN from Staphylococcus delphini provided insights into the physical basis for our functional observations. Along with our previous studies on the SPIN/MPO interaction, this work lays a foundation for broadly defining the structure/function principles that underlie host-specific evolution of immune evasion proteins.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry & Molecular Biophysics, Kansas State University, Manhattan, Kansas, USA.
- Kansas Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, Kansas, USA.
- Wildcat Vet Services, Manhattan, Kansas, USA.
- Little Apple Veterinary Hospital, Manhattan, Kansas, USA.
- Department of Biochemistry & Molecular Biophysics, Kansas State University, Manhattan, Kansas, USA. Electronic address: geisbrechtb@ksu.edu.
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institute of General Medical Sciences
- National Institute of Food and Agriculture
Zitieren
APA
Fatehi, S., Herdendorf, T. J., Burklund, A., Kvasnica, T., Lindquist, E., Kittana, H., & Geisbrecht, B. V. (2026). Structural and kinetic basis for selective inhibition of canine myeloperoxidase by staphylococcal peroxidase inhibitor (SPIN) orthologs. Journal of Biological Chemistry, 302(12), 113649. https://doi.org/10.1016/j.jbc.2026.113649
Vancouver
Fatehi S, Herdendorf TJ, Burklund A, Kvasnica T, Lindquist E, Kittana H, et al. Structural and kinetic basis for selective inhibition of canine myeloperoxidase by staphylococcal peroxidase inhibitor (SPIN) orthologs. Journal of Biological Chemistry. 2026;302(12):113649. doi:10.1016/j.jbc.2026.113649
BibTeX
@article{Fatehi2026,
author = {Fatehi, Soheila and Herdendorf, Timothy J and Burklund, Amy and Kvasnica, Trisha and Lindquist, Elizabeth and Kittana, Hatem and Geisbrecht, Brian V},
title = {Structural and kinetic basis for selective inhibition of canine myeloperoxidase by staphylococcal peroxidase inhibitor (SPIN) orthologs},
journal = {Journal of Biological Chemistry},
year = {2026},
volume = {302},
number = {12},
pages = {113649},
doi = {10.1016/j.jbc.2026.113649}
}
EUVIMED